Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events

Intrauterine Growth Restriction (IUGR) incidence in Indonesia ranks in the top 10 of the highest in Asia. It is the main perinatal death cause. IUGR also impairs fetal neurodevelopment, which can affect the development of children until later ages. Lack of 11β-hydroxysteroid dehydrogenase type-2 (11...

Full description

Bibliographic Details
Main Authors: Louis Fabio Jonathan Jusni, Patricia Patricia, Brigitte Leonie Rosadi
Format: Article
Language:English
Published: Cell and BioPharmaceutical Institute 2021-11-01
Series:MCBS (Molecular and Cellular Biomedical Sciences)
Online Access:https://cellbiopharm.com/ojs/index.php/MCBS/article/view/214
_version_ 1818928529327259648
author Louis Fabio Jonathan Jusni
Patricia Patricia
Brigitte Leonie Rosadi
author_facet Louis Fabio Jonathan Jusni
Patricia Patricia
Brigitte Leonie Rosadi
author_sort Louis Fabio Jonathan Jusni
collection DOAJ
description Intrauterine Growth Restriction (IUGR) incidence in Indonesia ranks in the top 10 of the highest in Asia. It is the main perinatal death cause. IUGR also impairs fetal neurodevelopment, which can affect the development of children until later ages. Lack of 11β-hydroxysteroid dehydrogenase type-2 (11β-HSD2) enzyme is influenced by changes in the coding gene, HSD11B2, one of IUGR's causes. The main diagnostic method of IUGR at this time is by using Doppler ultrasound. However, Doppler ultrasound has several limitations as many cases are not detected. Its clinical predictive value in various women is poor, as Doppler ultrasound is not recommended for use in the first trimester, detection of abnormalities in the second trimester seems to be too late for helpful interventions. The study aim is to present an overview concerning HSD11B2 gene alteration in an non-invasive prenatal testing (NIPT) as a possible diagnostic parameter for early detection in IUGR infants. This literature review is based on selected articles and studies taken from the Pubmed, Proquest, and EBSCO databases. A total of 4 studies reported the tendency for DNA methylation and decreased expression of the HSD11B2 gene in IUGR cases. Changes in the HSD11B2 gene have the potential to become a diagnostic parameter in the early detection of infants with IUGR. Further study and investigation of this possibility are needed. Keywords: intrauterine growth restriction, HSD11B2, early detection, diagnostic, non-invasive prenatal testing
first_indexed 2024-12-20T03:30:21Z
format Article
id doaj.art-66675eb1720846fca90483f92d608e40
institution Directory Open Access Journal
issn 2527-4384
2527-3442
language English
last_indexed 2024-12-20T03:30:21Z
publishDate 2021-11-01
publisher Cell and BioPharmaceutical Institute
record_format Article
series MCBS (Molecular and Cellular Biomedical Sciences)
spelling doaj.art-66675eb1720846fca90483f92d608e402022-12-21T19:55:00ZengCell and BioPharmaceutical InstituteMCBS (Molecular and Cellular Biomedical Sciences)2527-43842527-34422021-11-01539810310.21705/mcbs.v5i3.21478Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) EventsLouis Fabio Jonathan Jusni0Patricia Patricia1Brigitte Leonie Rosadi2Faculty of Medicine and Health Science, Atma Jaya Catholic University of Indonesia, JakartaFaculty of Medicine and Health Science, Atma Jaya Catholic University of Indonesia, JakartaFaculty of Medicine and Health Science, Atma Jaya Catholic University of Indonesia, JakartaIntrauterine Growth Restriction (IUGR) incidence in Indonesia ranks in the top 10 of the highest in Asia. It is the main perinatal death cause. IUGR also impairs fetal neurodevelopment, which can affect the development of children until later ages. Lack of 11β-hydroxysteroid dehydrogenase type-2 (11β-HSD2) enzyme is influenced by changes in the coding gene, HSD11B2, one of IUGR's causes. The main diagnostic method of IUGR at this time is by using Doppler ultrasound. However, Doppler ultrasound has several limitations as many cases are not detected. Its clinical predictive value in various women is poor, as Doppler ultrasound is not recommended for use in the first trimester, detection of abnormalities in the second trimester seems to be too late for helpful interventions. The study aim is to present an overview concerning HSD11B2 gene alteration in an non-invasive prenatal testing (NIPT) as a possible diagnostic parameter for early detection in IUGR infants. This literature review is based on selected articles and studies taken from the Pubmed, Proquest, and EBSCO databases. A total of 4 studies reported the tendency for DNA methylation and decreased expression of the HSD11B2 gene in IUGR cases. Changes in the HSD11B2 gene have the potential to become a diagnostic parameter in the early detection of infants with IUGR. Further study and investigation of this possibility are needed. Keywords: intrauterine growth restriction, HSD11B2, early detection, diagnostic, non-invasive prenatal testinghttps://cellbiopharm.com/ojs/index.php/MCBS/article/view/214
spellingShingle Louis Fabio Jonathan Jusni
Patricia Patricia
Brigitte Leonie Rosadi
Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
MCBS (Molecular and Cellular Biomedical Sciences)
title Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
title_full Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
title_fullStr Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
title_full_unstemmed Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
title_short Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
title_sort alteration in 11 beta hydroxysteroid dehydrogenase type 2 hsd11b2 gene as a potential candidate parameter for early detection of intrauterine growth restriction iugr events
url https://cellbiopharm.com/ojs/index.php/MCBS/article/view/214
work_keys_str_mv AT louisfabiojonathanjusni alterationin11betahydroxysteroiddehydrogenasetype2hsd11b2geneasapotentialcandidateparameterforearlydetectionofintrauterinegrowthrestrictioniugrevents
AT patriciapatricia alterationin11betahydroxysteroiddehydrogenasetype2hsd11b2geneasapotentialcandidateparameterforearlydetectionofintrauterinegrowthrestrictioniugrevents
AT brigitteleonierosadi alterationin11betahydroxysteroiddehydrogenasetype2hsd11b2geneasapotentialcandidateparameterforearlydetectionofintrauterinegrowthrestrictioniugrevents